McElhenny Sheffield Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $510K | Sell |
4,744
-350
| -7% | -$37.6K | 0.14% | 49 |
|
|
2025
Q1 | $514K | Buy |
+5,094
| New | +$514K | 0.19% | 47 |
|
|
2023
Q4 | – | Sell |
-12,986
| Closed | -$686K | – | 92 |
|
|
2023
Q3 | $686K | Sell |
12,986
-1,762
| -12% | -$93K | 0.35% | 26 |
|
|
2023
Q2 | $798K | Sell |
14,748
-2,194
| -13% | -$119K | 0.34% | 27 |
|
|
2023
Q1 | $848K | Sell |
16,942
-2,895
| -15% | -$145K | 0.45% | 32 |
|
|
2022
Q4 | $918K | Sell |
19,837
-3,703
| -16% | -$171K | 0.42% | 28 |
|
|
2022
Q3 | $912K | Buy |
+23,540
| New | +$912K | 0.7% | 25 |
|
|
2021
Q4 | – | Sell |
-29,900
| Closed | -$1.3M | – | 125 |
|
|
2021
Q3 | $1.3M | Buy |
+29,900
| New | +$1.3M | 0.59% | 18 |
|